211 related articles for article (PubMed ID: 36786081)
21. Hereditary myeloid malignancies.
Rafei H; DiNardo CD
Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998
[TBL] [Abstract][Full Text] [Related]
22. Germline Predisposition to Hematolymphoid Neoplasia.
Weinberg OK; Kuo F; Calvo KR
Am J Clin Pathol; 2019 Aug; 152(3):258-276. PubMed ID: 31309983
[TBL] [Abstract][Full Text] [Related]
23. Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice.
Tsoulaki O; Tischkowitz M; Antoniou AC; Musgrave H; Rea G; Gandhi A; Cox K; Irvine T; Holcombe S; Eccles D; Turnbull C; Cutress R; ; Archer S; Hanson H
Br J Cancer; 2024 Jun; 130(12):2027-2036. PubMed ID: 38834743
[TBL] [Abstract][Full Text] [Related]
24. Myeloid Malignancies: Recognizing the Risk of Germline Predisposition and Supporting Patients and Families.
Friend P; Mahon SM
Clin J Oncol Nurs; 2021 Oct; 25(5):519-522. PubMed ID: 34533515
[TBL] [Abstract][Full Text] [Related]
25. Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.
Trottier AM; Feurstein S; Godley LA
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101537. PubMed ID: 38490765
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic evaluation and considerations in hypocellular bone marrow failure-A focus on genomics.
Fox LC; Wood EM; Ritchie DS; Blombery P
Int J Lab Hematol; 2020 Jun; 42 Suppl 1():82-89. PubMed ID: 32134198
[TBL] [Abstract][Full Text] [Related]
27. Hematological Malignancies in Adults With a Family Predisposition.
Bochtler T; Haag GM; Schott S; Kloor M; Krämer A; Müller-Tidow C
Dtsch Arztebl Int; 2018 Dec; 115(50):848-854. PubMed ID: 30722840
[TBL] [Abstract][Full Text] [Related]
28. Multiple Primary Cancers With Hematologic Malignancies and Germline Predisposition: A Case Series.
Yun J; Lee DS; Lee S; Yun H
Ann Lab Med; 2024 Sep; 44(5):446-449. PubMed ID: 38449380
[TBL] [Abstract][Full Text] [Related]
29. Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies.
Schlegelberger B; Mecucci C; Wlodarski M
Fam Cancer; 2021 Oct; 20(4):295-303. PubMed ID: 34057692
[TBL] [Abstract][Full Text] [Related]
30. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.
Moriyama T; Metzger ML; Wu G; Nishii R; Qian M; Devidas M; Yang W; Cheng C; Cao X; Quinn E; Raimondi S; Gastier-Foster JM; Raetz E; Larsen E; Martin PL; Bowman WP; Winick N; Komada Y; Wang S; Edmonson M; Xu H; Mardis E; Fulton R; Pui CH; Mullighan C; Evans WE; Zhang J; Hunger SP; Relling MV; Nichols KE; Loh ML; Yang JJ
Lancet Oncol; 2015 Dec; 16(16):1659-66. PubMed ID: 26522332
[TBL] [Abstract][Full Text] [Related]
31. New progress in the study of germline susceptibility genes of myeloid neoplasms.
Bi L; Ma T; Li X; Wei L; Liu Z; Feng B; Dong B; Chen X
Oncol Lett; 2021 Apr; 21(4):317. PubMed ID: 33692849
[TBL] [Abstract][Full Text] [Related]
32. Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology.
Roloff GW; Drazer MW; Godley LA
JCO Precis Oncol; 2021 Nov; 5():107-122. PubMed ID: 34994594
[TBL] [Abstract][Full Text] [Related]
33. Molecular study of CEBPA in familial hematological malignancies.
El Abed R; Bourdon V; Huiart L; Eisinger F; Khelif A; Frenay M; Gesta P; Demange L; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Sauvan R; Soua Z; Sobol H
Fam Cancer; 2009; 8(4):581-4. PubMed ID: 19731081
[TBL] [Abstract][Full Text] [Related]
34. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities.
Trottier AM; Godley LA
Br J Haematol; 2021 Aug; 194(4):663-676. PubMed ID: 33615436
[TBL] [Abstract][Full Text] [Related]
35. Identifying patients with genetic predisposition to acute myeloid leukemia.
Obrochta E; Godley LA
Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
[TBL] [Abstract][Full Text] [Related]
36. Germline Genetic Predisposition to Hematologic Malignancy.
Furutani E; Shimamura A
J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
[TBL] [Abstract][Full Text] [Related]
37. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner.
Bogaert DJ; Laureys G; Naesens L; Mazure D; De Bruyne M; Hsu AP; Bordon V; Wouters E; Tavernier SJ; Lambrecht BN; De Baere E; Haerynck F; Kerre T
Br J Haematol; 2020 Mar; 188(5):768-773. PubMed ID: 31710708
[TBL] [Abstract][Full Text] [Related]
38. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
Király AP; Kállay K; Gángó A; Kellner Á; Egyed M; Szőke A; Kiss R; Vályi-Nagy I; Csomor J; Matolcsy A; Bödör C
Pathol Oncol Res; 2018 Jan; 24(1):83-88. PubMed ID: 28357685
[TBL] [Abstract][Full Text] [Related]
39. Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis.
Miller LH; Qu CK; Pauly M
Exp Hematol; 2018 Oct; 66():17-26. PubMed ID: 30076950
[TBL] [Abstract][Full Text] [Related]
40. Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA).
Miller P; Patel SR; Skinner R; Dignan F; Richter A; Jeffery K; Khan A; Heath PT; Clark A; Orchard K; Snowden JA; de Silva TI
J Infect; 2023 Jan; 86(1):1-8. PubMed ID: 36400155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
